News & Updates

Patients on high-dose citalopram (>20 mg) and high-dose escitalopram (>10 mg) are more likely to experience out-of-hospital cardiac arrest (OHCA) than those on sertraline, while users of high-dose mirtazapine (>30 mg) have a higher OHCA rate than those on duloxetine, a study has shown.

In patients diagnosed with opioid use disorders, those who received medication-assisted therapy (MAT) prescriptions have a higher risk of cardiac arrhythmia than those who did not, reports a study.

The implantation of self-expanding aortic values appears to trigger strong spikes in PR and QRS intervals, leading to high rates of high-degree cardiac conduction disturbances (HDCD) after hospital discharge, a recent study has found.

Cardiothoracic ratios (CTR) are lower than the mean and R wave amplitudes are decreased in acutely malnourished children, reports a preliminary study presented at the 54th Annual Meeting of the European Society for Paediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN 2022).

The use of oral contraceptive and hormone replacement therapy may put women at heightened risk of stroke, especially within the first year of use, possibly due to immediate changes in haemostatic balance, according to a study.

Inability to stand on one leg for 10 seconds (sec) is strongly linked to a higher risk of death, and consequently, a shorter life expectancy in older adults, according to a study in Brazil.

Patients with symptomatic internal carotid artery (ICA) stenosis may fare well with revacept, a competitive antagonist of glycoprotein VI, as the drug helps reduce the incidence of stroke or death, transient ischaemic attack, and bleeding complications, among others, according to a study.

Bleeding and mortality risks are elevated in atrial fibrillation (AF) patients treated with nonvitamin K antagonist oral anticoagulant (NOAC) who are also using P-glycoprotein (P-gp) and CYP3A4 inhibitors, reports a study, noting the need for close monitoring of these individuals.